12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·08/26/2025 17:06:55
Listen to the news
Gainers
- Allarity Therapeutics (NASDAQ:ALLR) shares moved upwards by 116.2% to $2.04 during Tuesday's regular session. The company's market cap stands at $13.7 million.
- Invivyd (NASDAQ:IVVD) stock increased by 85.81% to $1.04. The market value of their outstanding shares is at $67.2 million.
- SCWorx (NASDAQ:WORX) shares moved upwards by 28.26% to $0.37. The market value of their outstanding shares is at $2.2 million.
- Sera Prognostics (NASDAQ:SERA) stock rose 17.99% to $3.12. The market value of their outstanding shares is at $100.4 million.
- Orchestra BioMed Hldgs (NASDAQ:OBIO) shares rose 15.76% to $3.01. The company's market cap stands at $140.2 million.
- Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 14.7% to $1.17. The market value of their outstanding shares is at $5.2 million.
Losers
- ESSA Pharma (NASDAQ:EPIX) stock fell 66.0% to $0.27 during Tuesday's regular session. The company's market cap stands at $37.0 million.
- Femasys (NASDAQ:FEMY) shares declined by 38.31% to $0.32. The company's market cap stands at $16.7 million.
- Tharimmune (NASDAQ:THAR) shares decreased by 17.0% to $6.4. The company's market cap stands at $40.6 million.
- Cognition Therapeutics (NASDAQ:CGTX) shares decreased by 15.75% to $2.68. The company's market cap stands at $233.6 million.
- Virax Biolabs Group (NASDAQ:VRAX) stock declined by 14.31% to $0.66. The company's market cap stands at $3.3 million.
- NLS Pharmaceutics (NASDAQ:NLSP) shares decreased by 13.47% to $2.12. The market value of their outstanding shares is at $12.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.